BIODESIX, INC. Operating Cash Flow
BIODESIX, INC. (BDSX) reported Operating Cash Flow of -$11.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- BIODESIX, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.56M.
- BIODESIX, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$10.17M.
- BIODESIX, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $778.00K.
- BIODESIX, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$8.88M.
- BIODESIX, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$23.27M.
- BIODESIX, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$48.65M.
- BIODESIX, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$22.87M.
- BIODESIX, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$44.97M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$11.73M 10-Q · filed 2026-08-05 | -$10.95M derived: sum of 3 quarters · filed 2026-08-05 | -$19.83M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$10.17M 10-Q · filed 2026-05-04 | -$9.39M derived: sum of 2 quarters · filed 2026-05-04 | -$18.27M derived: sum of 3 quarters · filed 2026-05-04 | -$24.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $778.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$8.10M derived: sum of 2 quarters · filed 2026-02-26 | -$14.67M derived: sum of 3 quarters · filed 2026-08-05 | -$23.27M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$8.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$15.45M derived: sum of 2 quarters · filed 2026-08-05 | -$24.05M 10-Q · filed 2025-11-03 | -$28.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$6.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$15.17M 10-Q · filed 2026-08-05 | -$19.27M derived: sum of 3 quarters · filed 2026-08-05 | -$29.94M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$8.60M 10-Q · filed 2026-05-04 | -$12.70M derived: sum of 2 quarters · filed 2026-05-04 | -$23.37M derived: sum of 3 quarters · filed 2026-05-04 | -$41.94M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$14.77M derived: sum of 2 quarters · filed 2026-02-26 | -$33.34M derived: sum of 3 quarters · filed 2026-02-26 | -$48.65M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$10.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$29.24M derived: sum of 2 quarters · filed 2025-11-03 | -$44.55M 10-Q · filed 2025-11-03 | -$56.84M derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | -$18.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$33.88M 10-Q · filed 2025-08-07 | -$46.16M derived: sum of 3 quarters · filed 2025-08-07 | -$50.00M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$15.31M 10-Q · filed 2025-05-13 | -$27.59M derived: sum of 2 quarters · filed 2025-05-13 | -$31.43M derived: sum of 3 quarters · filed 2025-05-13 | -$30.50M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$12.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$16.12M derived: sum of 2 quarters · filed 2025-03-03 | -$15.18M derived: sum of 3 quarters · filed 2025-03-03 | -$22.87M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$3.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | -$2.90M derived: sum of 2 quarters · filed 2024-11-01 | -$10.59M 10-Q · filed 2024-11-01 | -$22.54M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $937.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$6.75M 10-Q · filed 2024-08-07 | -$18.70M derived: sum of 3 quarters · filed 2024-08-07 | -$29.03M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$7.69M 10-Q · filed 2024-05-08 | -$19.63M derived: sum of 2 quarters · filed 2024-05-08 | -$29.96M derived: sum of 3 quarters · filed 2024-05-08 | -$39.56M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$11.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$22.28M derived: sum of 2 quarters · filed 2024-03-01 | -$31.87M derived: sum of 3 quarters · filed 2024-03-01 | -$44.97M 10-K · filed 2024-03-01 |
| 2022-09-30 | -$10.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$19.93M derived: sum of 2 quarters · filed 2023-11-07 | -$33.02M 10-Q · filed 2023-11-07 | -$43.22M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$9.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$22.69M 10-Q · filed 2023-08-07 | -$32.89M derived: sum of 3 quarters · filed 2023-08-07 | -$40.68M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$13.10M 10-Q · filed 2023-05-11 | -$23.30M derived: sum of 2 quarters · filed 2023-05-11 | -$31.09M derived: sum of 3 quarters · filed 2023-05-11 | -$30.00M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$17.99M derived: sum of 2 quarters · filed 2023-03-06 | -$16.90M derived: sum of 3 quarters · filed 2023-03-06 | -$28.22M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$7.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$6.70M derived: sum of 2 quarters · filed 2022-11-03 | -$18.03M 10-Q · filed 2022-11-03 | -$26.78M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$10.24M 10-Q · filed 2022-08-04 | -$18.99M derived: sum of 3 quarters · filed 2022-08-04 | -$22.76M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$11.33M 10-Q · filed 2022-05-11 | -$20.08M derived: sum of 2 quarters · filed 2022-05-11 | -$23.85M derived: sum of 3 quarters · filed 2022-05-11 | -$28.16M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$8.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | -$12.53M derived: sum of 2 quarters · filed 2022-03-14 | -$16.83M derived: sum of 3 quarters · filed 2022-03-14 | -$21.37M 10-K · filed 2022-03-14 |
| 2020-09-30 | -$3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$8.07M derived: sum of 2 quarters · filed 2021-11-15 | -$12.61M 10-Q · filed 2021-11-15 | -$18.34M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$8.84M 10-Q · filed 2021-08-10 | -$14.57M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | -$4.54M 10-Q · filed 2021-05-11 | -$10.27M derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | -$5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$21.73M 10-K · filed 2021-03-16 | ||
| 2019-09-30 | -$16.00M 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |